Pathogenetic overview of psoriatic disease

Journal of Rheumatology

Volumn 39, Issue SUPPL. 89, 2012, Pages 7-10

  Haroon, Muhammad ^a   Fitzgerald, Oliver ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Genetics; Pathogenesis; Psoriatic arthritis; T lymphocytes

Indexed keywords

HLA B ANTIGEN; HLA B27 ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 17; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; AUTACOID; BIOLOGICAL MARKER;

ANGIOGENESIS; AUTOIMMUNE DISEASE; BONE MARROW EDEMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; ENTHESITIS; GENETIC ASSOCIATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; NEUTROPHIL CHEMOTAXIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; BONE REMODELING; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; JOINT; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; REVIEW; VASCULARIZATION;

ANIMALS; ARTHRITIS, PSORIATIC; AUTOIMMUNITY; BIOLOGICAL MARKERS; BONE REMODELING; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; JOINTS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 84864416642     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120232     Document Type: Conference Paper

References (32)

1. Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale JD, et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 2011;70:272-7. Erratum in: Ann Rheum Dis 2011;70:716.
2. Helliwell PS, FitzGerald O, Strand CV, Mease PJ. Composite measures in psoriatic arthritis: a report from the GRAPPA 2009 annual meeting. J Rheumatol 2011;38:540-5.
3. Veale D, FitzGerald O. Psoriatic arthritis. Best Pract Res Clin Rheumatol 2002;16:523-35.
4. van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006;65:1551-7. (Pubitemid 44799664)
5. Costello P, Bresnihan B, O'Farrelly C, FitzGerald O. Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol 1999;26:1117-24. (Pubitemid 29215077)
6. Curran SA, FitzGerald OM, Costello PJ, Selby JM, Kane DJ, Bresnihan B, et al. Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol 2004;172:1935-44. (Pubitemid 38116844)
7. Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 1987;123:1622-32. (Pubitemid 18012175)
8. Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987;106:19-26. (Pubitemid 17004678)
9. Daikeler T, Gunaydin I, Einsele H, Kanz L, Kotter I. Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor. Rheumatology 1999;38:89-90. (Pubitemid 29509664)
10. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 1997;137:130-2. (Pubitemid 27305925)
11. Spadaro A, Riccieri V, Sili-Scavalli A, Sensi F, Taccari E, Zoppini A. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clin Exp Rheumatol 1995;13:589-93.
12. Pontifex EK, Gerlag DM, Gogarty M, Vinkenoog M, Gibbs A, Burgman I, et al. Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy - a single centre, open-label study. Arthritis Res Ther 2011;13(1):R7.
13. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006;3(8):e297.
14. McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007;56:2482-91. (Pubitemid 47237267)
15. Winchester R. Genetics of psoriasis and psoriatic arthritis. In: Ritchlin CT, FitzGerald O, eds. Psoriatic and reactive arthritis - a companion to rheumatology. Amsterdam: Elsevier; 2007.
16. Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M. Psoriasis and HLA-Cw6. Br J Dermatol 1980;102:179-84. (Pubitemid 10148338)
17. Mallon E, Bunce M, Wojnarowska F, Welsh K. HLA-CW&z.ast;0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics. J Invest Dermatol 1997;109:183-6. (Pubitemid 27337333)
18. Leder RO, Mansbridge JN, Hallmayer J, Hodge SE. Familial psoriasis and HLA-B: unambiguous support for linkage in 97 published families. Hum Hered 1998;48:198-211. (Pubitemid 28362461)
19. Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 2011;Oct 17 (E-pub ahead of print).
20. Hüffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010;42:996-9.
21. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007;8:247-56. (Pubitemid 46745374)
22. Hunter CA. Act1-ivating IL-17 inflammation. Nat Immunol 2007;8:232-4. (Pubitemid 46745371)
23. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008;223:87-113. (Pubitemid 351986173)
24. Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 2010;42:991-5.
25. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36:893-900. (Pubitemid 23201103)
26. Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4. (Pubitemid 30265607)
27. Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J, et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005;7:R569-80.
28. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003;42:1460-8. (Pubitemid 37508919)
29. Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O'Connor P, et al. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis 2007;66:778-81. (Pubitemid 46846697)
30. Marzo-Ortega H, Tanner SF, Rhodes LA, Tan AL, Conaghan PG, Hensor EM, et al. Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand J Rheumatol 2009;38:79-83.
31. Finzel S, Englbrecht M, Engelke K, Stach C, Schett G. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 2011;70:122-7.
32. Szentpetery A, Ng CT, Murray BF, Brady JJ, Gallagher P, Van der Kamp S, et al. Markers of bone formation are increased in psoriatic arthritis compared to rheumatoid arthritis at baseline and increase further after 3 years of anti-TNF-therapy [abstract]. Arthritis Rheum 2009;60 Suppl:1783.